Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jacqueline Saw, MD
Vancouver General Hospital
Principal Investigator - Maurice Buchbinder, MD
Stanford University
Principal Investigator - Vivek Reddy, MD
Icahn School of Medicine at Mount Sinai
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
92 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Onze Lieve Vrouw Ziekenhuis
Aalst, Belgium
- Zna Middelheim
Antwerp, Belgium
- Ottawa Heart Institute
Ottawa, Canada
- Institut Universitaire de Cardiologie Et de Pneumologie de Quebec
Ste-foy, Canada
- Vancouver General Hospital
Vancouver, Canada
- Na Homolce Hospital
Prague, Czechia
- Aarhus University Hospital
Aarhus N, Denmark
- Rigshospitalet Copenhagen
Copenhagen, Denmark
- Universitaetsklinikum Dusseldorf
Düsseldorf, Germany
- St.Johann Nepomuk Katholisches Hospitalvereinigung Thüringen Gmbh
Erfurt, Germany
- Cardioangiologisches Centrum Bethanien
Frankfurt, Germany
- Cardiologicum Hamburg Praxis Wandsbek
Hamburg, Germany
- Herzzentrum Universität Leipzig
Leipzig, Germany
- Fondazione Toscana Gabriele Monasterio
Massa, Italy
- Medisch Spectrum Twente
Enschede, Netherlands
- St. Antonius Ziekenhuis
Nieuwegein, Netherlands
- Royal Victoria Hospital
Belfast, United Kingdom
- Royal Sussex County Hospital
Brighton, United Kingdom
- Guys and St. Thomas Nhs Foundation Trust
London, United Kingdom
- the Brompton Hospital
London, United Kingdom
- John Radcliffe Hospital
Oxford, United Kingdom
- Grandview Medical Center
Birmingham, Alabama, United States
- Huntsville Hospital
Huntsville, Alabama, United States
- Arizona Arrhythmia Research Center
Phoenix, Arizona, United States
- Arrhythmia Research Group
Jonesboro, Arkansas, United States
- Scripps Memorial Hospital
La Jolla, California, United States
- Cedars - Sinai Medical Center
Los Angeles, California, United States
- Sharpe Chula Vista Medical Center
San Diego, California, United States
- Santa Barbara Cottage Hospital
Santa Barbara, California, United States
- St. John'S Health Center
Santa Monica, California, United States
- North Colorado Medical Center
Greeley, Colorado, United States
- St. Anthony Hospital
Lakewood, Colorado, United States
- Washington Hospital Center
Washington D.C., District of Columbia, United States
- Delray Medical Center
Delray Beach, Florida, United States
- Lakeland Regional Medical Center
Lakeland, Florida, United States
- Sarasota Memorial Hospital
Sarasota, Florida, United States
- Tallahassee Memorial Hospital
Tallahassee, Florida, United States
- Bay Area Cardiology Associates
Tampa, Florida, United States
- Tampa General Hospital
Tampa, Florida, United States
- Emory University Hospital
Atlanta, Georgia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Feb 2017
- Primary completion
- 23 Sept 2025
- Completion
- 23 Sept 2025
- Last update posted
- 13 Apr 2026
- Registered enrollment
- 481
- Registry id
- NCT02928497
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.